Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Viruses control dominant bacteria colonizing the terrestrial deep biosphere after hydraulic fracturing.

Daly RA, Roux S, Borton MA, Morgan DM, Johnston MD, Booker AE, Hoyt DW, Meulia T, Wolfe RA, Hanson AJ, Mouser PJ, Moore JD, Wunch K, Sullivan MB, Wrighton KC, Wilkins MJ.

Nat Microbiol. 2019 Feb;4(2):352-361. doi: 10.1038/s41564-018-0312-6. Epub 2018 Dec 3.

2.

Comparative genomics and physiology of the genus Methanohalophilus, a prevalent methanogen in hydraulically fractured shale.

Borton MA, Daly RA, O'Banion B, Hoyt DW, Marcus DN, Welch S, Hastings SS, Meulia T, Wolfe RA, Booker AE, Sharma S, Cole DR, Wunch K, Moore JD, Darrah TH, Wilkins MJ, Wrighton KC.

Environ Microbiol. 2018 Dec;20(12):4596-4611. doi: 10.1111/1462-2920.14467.

PMID:
30394652
3.

Viral and metabolic controls on high rates of microbial sulfur and carbon cycling in wetland ecosystems.

Dalcin Martins P, Danczak RE, Roux S, Frank J, Borton MA, Wolfe RA, Burris MN, Wilkins MJ.

Microbiome. 2018 Aug 7;6(1):138. doi: 10.1186/s40168-018-0522-4.

4.

Risk Factors for Falls in Adult Cancer Survivors: An Integrative Review.

Campbell G, Wolfe RA, Klem ML.

Rehabil Nurs. 2018 Jul/Aug;43(4):201-213. doi: 10.1097/rnj.0000000000000173. Review.

5.

Coupled laboratory and field investigations resolve microbial interactions that underpin persistence in hydraulically fractured shales.

Borton MA, Hoyt DW, Roux S, Daly RA, Welch SA, Nicora CD, Purvine S, Eder EK, Hanson AJ, Sheets JM, Morgan DM, Wolfe RA, Sharma S, Carr TR, Cole DR, Mouser PJ, Lipton MS, Wilkins MJ, Wrighton KC.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6585-E6594. doi: 10.1073/pnas.1800155115. Epub 2018 Jun 25.

6.

Sulfide Generation by Dominant Halanaerobium Microorganisms in Hydraulically Fractured Shales.

Booker AE, Borton MA, Daly RA, Welch SA, Nicora CD, Hoyt DW, Wilson T, Purvine SO, Wolfe RA, Sharma S, Mouser PJ, Cole DR, Lipton MS, Wrighton KC, Wilkins MJ.

mSphere. 2017 Jul 5;2(4). pii: e00257-17. doi: 10.1128/mSphereDirect.00257-17. eCollection 2017 Jul-Aug.

7.

Chemical and pathogen-induced inflammation disrupt the murine intestinal microbiome.

Borton MA, Sabag-Daigle A, Wu J, Solden LM, O'Banion BS, Daly RA, Wolfe RA, Gonzalez JF, Wysocki VH, Ahmer BMM, Wrighton KC.

Microbiome. 2017 Apr 27;5(1):47. doi: 10.1186/s40168-017-0264-8.

8.

Microbial metabolisms in a 2.5-km-deep ecosystem created by hydraulic fracturing in shales.

Daly RA, Borton MA, Wilkins MJ, Hoyt DW, Kountz DJ, Wolfe RA, Welch SA, Marcus DN, Trexler RV, MacRae JD, Krzycki JA, Cole DR, Mouser PJ, Wrighton KC.

Nat Microbiol. 2016 Sep 5;1:16146. doi: 10.1038/nmicrobiol.2016.146.

PMID:
27595198
9.

On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.

Li Y, Lee Y, Wolfe RA, Morgenstern H, Zhang J, Port FK, Robinson BM.

Stat Med. 2015 Mar 30;34(7):1150-68. doi: 10.1002/sim.6404. Epub 2014 Dec 29.

10.

Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality.

Ramirez SP, Kapke A, Port FK, Wolfe RA, Saran R, Pearson J, Hirth RA, Messana JM, Daugirdas JT.

Clin J Am Soc Nephrol. 2012 Dec;7(12):1977-87. doi: 10.2215/CJN.00390112. Epub 2012 Sep 13.

11.

Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

Robinson BM, Tong L, Zhang J, Wolfe RA, Goodkin DA, Greenwood RN, Kerr PG, Morgenstern H, Li Y, Pisoni RL, Saran R, Tentori F, Akizawa T, Fukuhara S, Port FK.

Kidney Int. 2012 Sep;82(5):570-80. doi: 10.1038/ki.2012.136. Epub 2012 Jun 20.

12.

Spectrum of cancer risk among US solid organ transplant recipients.

Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M.

JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.

13.

Transplanting kidneys without points for HLA-B matching: consequences of the policy change.

Ashby VB, Port FK, Wolfe RA, Wynn JJ, Williams WW, Roberts JP, Leichtman AB.

Am J Transplant. 2011 Aug;11(8):1712-8. doi: 10.1111/j.1600-6143.2011.03606.x. Epub 2011 Jun 14.

14.

Improving the allocation system for deceased-donor kidneys.

Leichtman AB, McCullough KP, Wolfe RA.

N Engl J Med. 2011 Apr 7;364(14):1287-9. doi: 10.1056/NEJMp1102728. Epub 2011 Mar 16. No abstract available.

PMID:
21410390
15.

Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practices.

Pisoni RL, Bragg-Gresham JL, Fuller DS, Morgenstern H, Canaud B, Locatelli F, Li Y, Gillespie B, Wolfe RA, Port FK, Robinson BM.

Am J Kidney Dis. 2011 Feb;57(2):266-75. doi: 10.1053/j.ajkd.2010.11.003.

PMID:
21251541
16.

Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation.

Mathur AK, Ashby VB, Sands RL, Wolfe RA.

Am J Transplant. 2010 Apr;10(4 Pt 2):1069-80. doi: 10.1111/j.1600-6143.2010.03043.x.

17.

Trends in organ donation and transplantation in the United States, 1999-2008.

Wolfe RA, Roys EC, Merion RM.

Am J Transplant. 2010 Apr;10(4 Pt 2):961-72. doi: 10.1111/j.1600-6143.2010.03021.x. No abstract available.

18.

Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization.

Axelrod DA, Sung RS, Meyer KH, Wolfe RA, Kaufman DB.

Am J Transplant. 2010 Apr;10(4):837-45. doi: 10.1111/j.1600-6143.2009.02996.x. Epub 2010 Feb 1.

19.

Predictability of survival models for waiting list and transplant patients: calculating LYFT.

Wolfe RA, McCullough KP, Leichtman AB.

Am J Transplant. 2009 Jul;9(7):1523-7. doi: 10.1111/j.1600-6143.2009.02708.x.

20.

A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index.

Rao PS, Schaubel DE, Guidinger MK, Andreoni KA, Wolfe RA, Merion RM, Port FK, Sung RS.

Transplantation. 2009 Jul 27;88(2):231-6. doi: 10.1097/TP.0b013e3181ac620b.

PMID:
19623019
21.

Rosiglitazone is associated with mortality in chronic hemodialysis patients.

Ramirez SP, Albert JM, Blayney MJ, Tentori F, Goodkin DA, Wolfe RA, Young EW, Bailie GR, Pisoni RL, Port FK.

J Am Soc Nephrol. 2009 May;20(5):1094-101. doi: 10.1681/ASN.2008060579. Epub 2009 Apr 8.

22.

Trends in organ donation and transplantation in the United States, 1998-2007.

Wolfe RA, Merion RM, Roys EC, Port FK.

Am J Transplant. 2009 Apr;9(4 Pt 2):869-78. doi: 10.1111/j.1600-6143.2009.02564.x. No abstract available.

23.

Laplace's approximation for relative risk frailty models.

Feng S, Nie L, Wolfe RA.

Lifetime Data Anal. 2009 Sep;15(3):343-56. doi: 10.1007/s10985-009-9112-x. Epub 2009 Jan 31.

PMID:
19184420
24.

Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.

Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK.

Am J Kidney Dis. 2009 Mar;53(3):475-91. doi: 10.1053/j.ajkd.2008.10.043. Epub 2009 Jan 15.

PMID:
19150158
25.

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.

Tentori F, Albert JM, Young EW, Blayney MJ, Robinson BM, Pisoni RL, Akiba T, Greenwood RN, Kimata N, Levin NW, Piera LM, Saran R, Wolfe RA, Port FK.

Nephrol Dial Transplant. 2009 Mar;24(3):963-72. doi: 10.1093/ndt/gfn592. Epub 2008 Nov 21.

PMID:
19028748
26.

Evaluation of dialysis performance measures.

Wolfe RA, Port FK.

Am J Kidney Dis. 2008 May;51(5):867-8; author reply 868-9. doi: 10.1053/j.ajkd.2007.12.046. No abstract available.

PMID:
18436103
27.

A practice-related risk score (PRS): a DOPPS-derived aggregate quality index for haemodialysis facilities.

Mendelssohn DC, Pisoni RL, Arrington CJ, Yeates KE, Leblanc M, Deziel C, Akiba T, Krishnan M, Fukuhara S, Lameire N, Port FK, Wolfe RA.

Nephrol Dial Transplant. 2008 Oct;23(10):3227-33. doi: 10.1093/ndt/gfn195. Epub 2008 Apr 18.

PMID:
18424461
28.

SRTR program-specific reports on outcomes: a guide for the new reader.

Dickinson DM, Arrington CJ, Fant G, Levine GN, Schaubel DE, Pruett TL, Roberts MS, Wolfe RA.

Am J Transplant. 2008 Apr;8(4 Pt 2):1012-26. doi: 10.1111/j.1600-6143.2008.02178.x.

29.

Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates.

Wolfe RA, McCullough KP, Schaubel DE, Kalbfleisch JD, Murray S, Stegall MD, Leichtman AB.

Am J Transplant. 2008 Apr;8(4 Pt 2):997-1011. doi: 10.1111/j.1600-6143.2008.02177.x.

30.

Trends in organ donation and transplantation in the United States, 1997-2006.

Port FK, Merion RM, Roys EC, Wolfe RA.

Am J Transplant. 2008 Apr;8(4 Pt 2):911-21. doi: 10.1111/j.1600-6143.2008.02170.x. No abstract available.

31.

Using knowledge of multiple levels of variation in care to target performance incentives to providers.

Turenne MN, Hirth RA, Pan Q, Wolfe RA, Messana JM, Wheeler JR.

Med Care. 2008 Feb;46(2):120-6. doi: 10.1097/MLR.0b013e31815b9d7a.

PMID:
18219239
32.

Effect of body mass index on the survival benefit of liver transplantation.

Pelletier SJ, Schaubel DE, Wei G, Englesbe MJ, Punch JD, Wolfe RA, Port FK, Merion RM.

Liver Transpl. 2007 Dec;13(12):1678-83.

33.

Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients.

Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK.

Transplantation. 2007 Apr 27;83(8):1069-74.

PMID:
17452897
34.

Geographic variability in access to primary kidney transplantation in the United States, 1996-2005.

Ashby VB, Kalbfleisch JD, Wolfe RA, Lin MJ, Port FK, Leichtman AB.

Am J Transplant. 2007;7(5 Pt 2):1412-23.

35.

Developing organ offer and acceptance measures: when 'good' organs are turned down.

Wolfe RA, LaPorte FB, Rodgers AM, Roys EC, Fant G, Leichtman AB.

Am J Transplant. 2007;7(5 Pt 2):1404-11.

36.

Trends in organ donation and transplantation in the United States, 1996-2005.

Port FK, Merion RM, Finley MP, Goodrich NP, Wolfe RA.

Am J Transplant. 2007;7(5 Pt 2):1319-26. No abstract available.

38.

Recovery and utilization of deceased donor kidneys from small pediatric donors.

Pelletier SJ, Guidinger MK, Merion RM, Englesbe MJ, Wolfe RA, Magee JC, Sollinger HW.

Am J Transplant. 2006 Jul;6(7):1646-52.

39.

SRTR center-specific reporting tools: Posttransplant outcomes.

Dickinson DM, Shearon TH, O'Keefe J, Wong HH, Berg CL, Rosendale JD, Delmonico FL, Webb RL, Wolfe RA.

Am J Transplant. 2006;6(5 Pt 2):1198-211.

40.

Recent trends and results for organ donation and transplantation in the United States, 2005.

Port FK, Merion RM, Goodrich NP, Wolfe RA.

Am J Transplant. 2006;6(5 Pt 2):1095-100. No abstract available.

41.

Understanding the basic case-mix adjustment for the composite rate.

Wheeler JR, Messana JM, Turenne MN, Hirth RA, Pozniak AS, Pan Q, Chuang CC, Slish K, Tedeschi P, Roys EC, Wolfe RA.

Am J Kidney Dis. 2006 Apr;47(4):666-71.

PMID:
16564944
42.

A shared random effects model for censored medical costs and mortality.

Liu L, Wolfe RA, Kalbfleisch JD.

Stat Med. 2007 Jan 15;26(1):139-55.

PMID:
16526006
43.

Deceased-donor characteristics and the survival benefit of kidney transplantation.

Merion RM, Ashby VB, Wolfe RA, Distant DA, Hulbert-Shearon TE, Metzger RA, Ojo AO, Port FK.

JAMA. 2005 Dec 7;294(21):2726-33.

PMID:
16333008
44.

Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS).

Satayathum S, Pisoni RL, McCullough KP, Merion RM, Wikström B, Levin N, Chen K, Wolfe RA, Goodkin DA, Piera L, Asano Y, Kurokawa K, Fukuhara S, Held PJ, Port FK.

Kidney Int. 2005 Jul;68(1):330-7.

45.

Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study.

Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R.

Am J Kidney Dis. 2005 Apr;45(4):658-66.

PMID:
15806468
46.

Economic impact of case-mix adjusting the dialysis composite rate.

Hirth RA, Roys EC, Wheeler JR, Messana JM, Turenne MN, Saran R, Pozniak AS, Wolfe RA.

J Am Soc Nephrol. 2005 May;16(5):1172-6. Epub 2005 Mar 30.

47.

Hepatitis C is a risk factor for death after liver retransplantation.

Pelletier SJ, Schaubel DE, Punch JD, Wolfe RA, Port FK, Merion RM.

Liver Transpl. 2005 Apr;11(4):434-40.

48.

Analytical approaches for transplant research, 2004.

Schaubel DE, Dykstra DM, Murray S, Ashby VB, McCullough KP, Dickinson DM, Hulbert-Shearon TE, Webb RL, Wolfe RA.

Am J Transplant. 2005 Apr;5(4 Pt 2):950-7.

49.

Trends and results for organ donation and transplantation in the United States, 2004.

Port FK, Dykstra DM, Merion RM, Wolfe RA.

Am J Transplant. 2005 Apr;5(4 Pt 2):843-9. No abstract available.

50.

Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002.

Wolfe RA, Hulbert-Shearon TE, Ashby VB, Mahadevan S, Port FK.

Am J Kidney Dis. 2005 Jan;45(1):127-35.

PMID:
15696452

Supplemental Content

Loading ...
Support Center